Robert Stuart to B-Lymphocytes
This is a "connection" page, showing publications Robert Stuart has written about B-Lymphocytes.
Connection Strength
0.116
-
Phase I trial of bortezomib (PS-341; NSC 681239) and "nonhybrid" (bolus) infusion schedule of alvocidib (flavopiridol; NSC 649890) in patients with recurrent or refractory indolent B-cell neoplasms. Clin Cancer Res. 2014 Nov 15; 20(22):5652-62.
Score: 0.101
-
Overexpression of nucleolin in chronic lymphocytic leukemia cells induces stabilization of bcl2 mRNA. Blood. 2007 Apr 01; 109(7):3069-75.
Score: 0.015